Prestige Consumer Healthcare (PBH) Receivables - Net (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Receivables - Net of $190.5 million in Q4 2025, down 4.29% quarter-over-quarter from $199.0 million in Q3 2025, and up 13.86% on a YoY basis from $167.3 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Receivables - Net (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Receivables - Net history runs 15 years deep, the most recent figure standing at $190.5 million for Q4 2025.
- In Q4 2025, Receivables - Net rose 13.86% year-over-year to $190.5 million; the TTM figure through Dec 2025 stood at $190.5 million (up 13.86% YoY), while the FY2025 annual figure was $194.3 million, up 9.91% from the prior year.
- Receivables - Net was $190.5 million for Q4 2025 at Prestige Consumer Healthcare, down from $199.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $199.0 million in Q3 2025 to a low of $114.7 million in Q1 2021.
- Historically, Receivables - Net has averaged $160.1 million across 5 years, with a median of $161.0 million in 2023.
- The sharpest annual moves came in 2021 and 2025: Receivables - Net decreased 23.82% in 2021, then advanced 21.68% in 2025.
- A 5-year view of Receivables - Net shows it stood at $134.3 million in 2021, then grew by 17.0% to $157.1 million in 2022, then grew by 10.95% to $174.3 million in 2023, then declined by 4.02% to $167.3 million in 2024, then advanced by 13.86% to $190.5 million in 2025.
- The last three Receivables - Net figures came in at $190.5 million (Q4 2025), $199.0 million (Q3 2025), and $168.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Prestige Consumer Healthcare | 2.33 Bn | 2.26 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 190.46 Mn |
| Dec 31, 2025 | 190.46 Mn |
| Sep 30, 2025 | 199.00 Mn |
| Sep 30, 2025 | 199.00 Mn |
| Jun 30, 2025 | 168.41 Mn |
| Jun 30, 2025 | 168.41 Mn |
| Mar 31, 2025 | 194.29 Mn |
| Mar 31, 2025 | 194.29 Mn |
| Dec 31, 2024 | 167.27 Mn |
| Dec 31, 2024 | 167.27 Mn |
| Sep 30, 2024 | 163.55 Mn |
| Sep 30, 2024 | 163.55 Mn |
| Jun 30, 2024 | 171.70 Mn |
| Jun 30, 2024 | 171.70 Mn |
| Mar 31, 2024 | 176.78 Mn |
| Mar 31, 2024 | 176.78 Mn |
| Dec 31, 2023 | 174.29 Mn |
| Dec 31, 2023 | 174.29 Mn |
| Sep 30, 2023 | 158.46 Mn |
| Sep 30, 2023 | 158.46 Mn |